FI102189B1 - Menetelmä tippuribakteerin PIA-proteiinin tuottamiseksi ja eristämiseksi - Google Patents

Menetelmä tippuribakteerin PIA-proteiinin tuottamiseksi ja eristämiseksi

Info

Publication number
FI102189B1
FI102189B1 FI902569A FI902569A FI102189B1 FI 102189 B1 FI102189 B1 FI 102189B1 FI 902569 A FI902569 A FI 902569A FI 902569 A FI902569 A FI 902569A FI 102189 B1 FI102189 B1 FI 102189B1
Authority
FI
Finland
Prior art keywords
protein
producing
gonorrhea
isolating
bacterial
Prior art date
Application number
FI902569A
Other languages
English (en)
Swedish (sv)
Other versions
FI902569A0 (fi
FI102189B (fi
Inventor
Nicholas H Carbonetti
P Frederick Sparling
Original Assignee
Univ North Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ North Carolina filed Critical Univ North Carolina
Publication of FI902569A0 publication Critical patent/FI902569A0/fi
Priority to FI945110A priority Critical patent/FI101936B/fi
Application granted granted Critical
Publication of FI102189B1 publication Critical patent/FI102189B1/fi
Publication of FI102189B publication Critical patent/FI102189B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI902569A 1987-11-24 1990-05-23 Menetelmä tippuribakteerin PIA-proteiinin tuottamiseksi ja eristämisek si FI102189B (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI945110A FI101936B (fi) 1987-11-24 1994-10-31 Tippuribakteerien rokotteiden valmistusmenetelmä

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US12472787A 1987-11-24 1987-11-24
US12472787 1987-11-24
US24275888A 1988-09-09 1988-09-09
US24275888 1988-09-09
PCT/US1988/004225 WO1989004873A1 (en) 1987-11-24 1988-11-23 Production of gonorrheal pi proteins and vaccines
US8804225 1988-11-23

Publications (3)

Publication Number Publication Date
FI902569A0 FI902569A0 (fi) 1990-05-23
FI102189B1 true FI102189B1 (fi) 1998-10-30
FI102189B FI102189B (fi) 1998-10-30

Family

ID=26822891

Family Applications (1)

Application Number Title Priority Date Filing Date
FI902569A FI102189B (fi) 1987-11-24 1990-05-23 Menetelmä tippuribakteerin PIA-proteiinin tuottamiseksi ja eristämisek si

Country Status (12)

Country Link
US (2) US5736361A (fi)
EP (2) EP0395706B1 (fi)
JP (2) JP2803058B2 (fi)
KR (1) KR970011309B1 (fi)
AT (1) ATE169958T1 (fi)
AU (1) AU629807B2 (fi)
CA (1) CA1340506C (fi)
DE (1) DE3856240T2 (fi)
DK (1) DK175831B1 (fi)
FI (1) FI102189B (fi)
NO (1) NO302622B1 (fi)
WO (1) WO1989004873A1 (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340506C (en) * 1987-11-24 1999-04-20 Nicholas H. Carbonetti Production of gonorrheal pi proteins and vaccines
US7118757B1 (en) * 1988-12-19 2006-10-10 Wyeth Holdings Corporation Meningococcal class 1 outer-membrane protein vaccine
EP0575553B1 (en) * 1991-03-14 1998-12-16 Imclone Systems, Inc. Recombinant hybrid porin epitopes
AU7408494A (en) * 1993-07-30 1995-02-28 University Of North Carolina At Chapel Hill, The Production of gonorrheal pi proteins and vaccines in e. coli and salmonella
US7252828B2 (en) 1998-07-15 2007-08-07 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
IL146382A0 (en) * 1999-05-13 2002-07-25 American Cyanamid Co Adjuvant combination formulations
EP2364726A3 (en) * 1999-09-30 2011-11-09 Isis Innovation Limited Vaccine against neisseria infection
ES2391153T3 (es) * 2000-02-28 2012-11-22 Novartis Vaccines And Diagnostics S.R.L. Expresión heteróloga de proteínas de Neisseria
PL366031A1 (en) * 2000-11-10 2005-01-24 Wyeth Holdings Corporation Adjuvant combination formulations
EP1583517B1 (en) 2002-11-12 2019-06-12 The Brigham And Women's Hospital, Inc. Methods and products for treating staphylococcal infections
WO2004043405A2 (en) 2002-11-12 2004-05-27 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
ES2738112T3 (es) 2004-04-21 2020-01-20 Brigham & Womens Hospital Inc Péptidos de fijación a la poli-N-acetil glucosamina (PNAG/dPNAG) y procedimientos para el uso de los mismos
US7037698B2 (en) 2004-05-19 2006-05-02 Amano Enzyme Inc. Pyrroloquinoline quinone-dependent glucose dehydrogenase
WO2010011284A2 (en) 2008-07-21 2010-01-28 The Brigham And Women's Hospital, Inc. Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237224A (en) * 1974-11-04 1980-12-02 Board Of Trustees Of The Leland Stanford Jr. University Process for producing biologically functional molecular chimeras
US4203971A (en) * 1978-03-23 1980-05-20 Government Of The United States Neisseria gonorrhoeae vaccine
DE2814039C3 (de) * 1978-03-31 1981-02-19 Gesellschaft Fuer Biotechnologische Forschung Mbh (Gbf), 3300 Braunschweig Verfahren zur Herstellung von Hybrid-Bakterien
US4351761A (en) * 1978-05-15 1982-09-28 Research Corporation Purified antigen to test for Neisseria gonorrhoeae antibodies
US4220638A (en) * 1978-10-12 1980-09-02 Merck & Co., Inc. Antigenic complex from N. Gonorrhoeae
US4288557A (en) * 1978-10-12 1981-09-08 Merck & Co., Inc. Antigenic complex from N. gonorrhoeae
US4239749A (en) * 1979-09-27 1980-12-16 United States Of America Neisseria gonorrhoeae vaccine
FI63596C (fi) * 1981-10-16 1983-07-11 Orion Yhtymae Oy Mikrobdiagnostiskt foerfarande som grundar sig pao skiktshybridisering av nukleinsyror och vid foerfarandet anvaenda kombinationer av reagenser
WO1983003354A1 (en) * 1982-03-30 1983-10-13 Us Army Neisseria gonorrhoeae vaccine
EP0178863A1 (en) * 1984-10-15 1986-04-23 Schering Corporation Novel expression systems utilizing bacteriophage T7 promoters and gene sequences
US4681761A (en) * 1985-10-24 1987-07-21 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Major iron-regulated protein of Neisseria gonorrhoeae and its use as vaccine
US4786592A (en) * 1986-06-18 1988-11-22 Scripps Clinic And Research Foundation Neisseria gonorrhoeae lectin useful as a vaccine and diagnostic marker and means for producing this lectin
CA1340506C (en) * 1987-11-24 1999-04-20 Nicholas H. Carbonetti Production of gonorrheal pi proteins and vaccines

Also Published As

Publication number Publication date
DE3856240T2 (de) 1999-05-06
JPH10234388A (ja) 1998-09-08
EP0395706A1 (en) 1990-11-07
JPH03502881A (ja) 1991-07-04
ATE169958T1 (de) 1998-09-15
EP0869133A1 (en) 1998-10-07
CA1340506C (en) 1999-04-20
US6068992A (en) 2000-05-30
KR970011309B1 (ko) 1997-07-09
EP0395706B1 (en) 1998-08-19
JP3388171B2 (ja) 2003-03-17
FI902569A0 (fi) 1990-05-23
US5736361A (en) 1998-04-07
AU629807B2 (en) 1992-10-15
WO1989004873A1 (en) 1989-06-01
EP0395706A4 (en) 1991-11-13
JP2803058B2 (ja) 1998-09-24
NO902251D0 (no) 1990-05-22
NO902251L (no) 1990-07-18
KR890701750A (ko) 1989-12-21
FI102189B (fi) 1998-10-30
NO302622B1 (no) 1998-03-30
AU2795989A (en) 1989-06-14
DK128490D0 (da) 1990-05-23
DE3856240D1 (de) 1998-09-24
DK128490A (da) 1990-07-06
DK175831B1 (da) 2005-03-14

Similar Documents

Publication Publication Date Title
FI102189B1 (fi) Menetelmä tippuribakteerin PIA-proteiinin tuottamiseksi ja eristämiseksi
EP0192392A3 (en) Insulin receptor, its purification, its production in recombinant cells, dna therefor, antibodies to insulin receptor and their preparation, and pharmaceutical compositions containing them
EG19101A (en) Process for preparing of expression of human proapolipoprotein A.1.
FI871700A0 (fi) Produktion av en granulocytkoloni-stimulerande faktor med flera effekter.
NO20070618L (no) Forbindelser og fremgangsmater for immunterapi og diagnose av tuberkulose.
DE3177106D1 (en) Hybrid human leukocyte interferons, process for their microbial production, intermediates therefor and compositions containing them
EP0088195A3 (en) Messenger rna, production and use thereof
IL123641A0 (en) Circular dna molecule with conditional origin of replication method for preparing the same and use thereof in gene therapy
ATE90944T1 (de) Fuer ein hirudinaehnliches protein kodierende dns- sequenz und verfahren zur herstellung eines solchen proteins.
CA2290696A1 (en) Immunopotentiating composition
DE69333346T2 (de) Neuartiges p- selectin ligandenprotein
EP0546110A4 (en) New insulin-like growth factor binding protein igfbp-5
CA2090549A1 (en) Bacterial surface protein expression
ATE264913T1 (de) Protease-resistente analoge des thrombomodulin
AU8258591A (en) Human mk gene and protein sequence
DE69012377D1 (de) Polypeptid und dessen Herstellung.
EP0546074A4 (en) Genetic material encoding igfbp-5
RU94046362A (ru) Последовательности днк, плазмиды, применение плазмиды, растения, бактерии, применение последовательности днк, дрожжевые штаммы
ATE89317T1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
EP0072541A3 (en) Human leukocyte interferons, process for their microbial production, intermediates therefor and compositions containing them
DK0387646T3 (da) Achromobacter-protease I-gen og genprodukt deraf
DE3889562D1 (de) Rekombinante Plasmide, die zur Expression von heterologen Proteinen in Bacillus verwendet werden können.
SE8100241L (sv) Mikrobiologiskt framstelld polypeptid med samma aminosyrasekvens som hos proinsulinet av primater, dna och plasmider, vilka kodierar for denna sekvens mikroorganismer, som innehaller dessa genetiska informationer, ...
ATE60359T1 (de) Menschlicher b-zellen-differenzierungsfaktor und verfahren zu dessen herstellung.
TH10372EX (th) จีนเซฟาโลสปอรินแอเซทิลไฮโดรเลสและโปรตีนที่ประมวลรหัสไว้ในจีนดังกล่าว

Legal Events

Date Code Title Description
FG Patent granted

Owner name: THE UNIVERSITY OF NORTH CAROLINA

MA Patent expired